I didn’t expect President Bush to weigh in so quickly on therapeutic cloning. The very same day as the Korean researchers announced their remarkable breakthrough, the President promised to veto a House bill which would expand federal funding for stem cell studies: “I made it very clear to Congress that the use of… taxpayer’s money, to promote science which destroys life in order to save life, is–I’m against that.” And directly commenting on the Korean discovery, he added, “I’m very concerned about cloning. I worry about a world where cloning is acceptable.” I admire the man for his moral clarity (he knows where he stands); but I also think he’s quite wrong.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.